HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 02, February 2022 – A Step into The Future: Innovative Ideas to Shape the Technology of Tomorrow       » New Bio-inspired Material Could Replace Conventional Plastics       » Partnership for Development of AI-Powered Telehealth-Radiology Platform       » Delivering a Complete Digital Health Ecosystem through Strategic Partnership       » Motivational Robots to Help Improve Learning       » Hope for Vaccine Against Herpes Virus      
Vol 25, No. 02, February 2021   |   Issue PDF view/purchase
INSIDE INDUSTRY
CUHK Develops New Microbiotic Diagnostic System
The Chinese University of Hong Kong (CUHK) has recently developed a fully automated, low cost and rapid microrobotic diagnostic system with comparable sensitivity and specificity to clinical detection methods.

Research team from CUHK is currently studying the application of this microrobotic system for multiple pathogens including SARS-CoV-2. This system has been developed by a collaborative research team led by Professor Zhang Li, Associate Professor, Department of Mechanical and Automation Engineering, Professor Margaret IP, Professor, Department of Microbiology, Professor Joseph Sung, Mok Hing Yiu Professor of Medicine and Director of the Institute of Digestive Disease, and Professor Sunny Wong, Associate Professor, Department of Medicine and Therapeutics.

Pathogen detention is essential for accurate diagnosis of diseases. The soaring demand for rapid testing was exacerbated by the COVID-19 pandemic, leading to heavy workload for laboratory personnel on an unprecedented scale. With longer the hospitalisation of patients, the patients are at higher risk of being infected by pathogens that can be fatal. Prompt clinical diagnosis is critical for patients showing signs of suspected infection.

Pressures of the COVID-19 pandemic and existing medical needs, shortages of medical manpower and resources including the laboratories may delay diagnosis, which can result in the suspension of other necessary medical procedures. Professor Margaret Ip said, “With globalisation, the spread of infectious diseases is not restricted to geographical areas. To enhance the diagnosis of infections and control, testing using automatic rapid detection systems is the general trend.”

Professor Zhang Li and his team developed an innovative microrobotic detection system, integrating the novel fluorescent microrobots with an external magnetic actuation system to accurately detect specific pathogens in a short time. The microrobotic sensing probes areG. lucidum spores coated by a layer of iron oxide nanoparticles and functionalized with carbon dots. By analysing the changes in the fluorescence signal of the microrobots under green light excitation, the system can determine the presence of pathogen in patients’ samples. The system uses an external magnetic field to remotely actuate the microrobots, speeding up the fluorescence quenching, shortening the detection time.

The first generation of microrobotic detection system, “QuickCAS”, aimed to detect Clostridium difficile, a common pathogen of nosocomial infection. The research team is now entering clinical trials, with the goal of testing in hospitals next year. In view of the pandemic disease, the team has worked closely with Professor Margaret Ip in utilising the microrobotic detection system for the COVID-19 diagnosis. The development of multiple pathogens detection using the microrobotic detection system is underway, covering common pathogens such asStreptococcus pneumoniae, Salmonella, pathogenic Escherichia coli and Helicobacter pylori, and it is expected to benefit medical institutions worldwide.

Current chemical detection methods rely on reactions between pathogen and biomolecular reagents. These bioreagents typically need to be refrigerated or frozen to preserve their structure and viability. By contrast, the microrobots are stable for transportation and storage under room temperature.

Professor Zhang Li said, “As QuickCAS uses physical detection methods, the reagents do not require refrigeration. It successfully breaks through the pain points of current chemical detection methods. In the future, medical centres in remote and poor areas or small-scale healthcare service providers will have the opportunity to provide accurate clinical diagnostic services.”

Existing methods of C. diff detection take 2 to 4 hours, in comparison, QuickCAS only takes 15 to 30 minutes to complete, and the cost has been greatly reduced from approximately HK$300 to about HK$50 per test. The automated system can not only provide hospitals with timely diagnosis and treatment for patients, but also reduce the workload and the risk of infection of medical staff during laboratory tests. Moreover, infection controls can be implemented earlier to prevent infection outbreak. Simplifying the testing procedures, can help in alleviating the pressure from the current shortage of experienced manpower.

NEWS CRUNCH  
news CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy